Filtered By:
Cancer: Cervical Cancer
Countries: France Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 96 results found since Jan 2013.
Link between the referring physician and breast and cervical cancers screening: a cross-sectional study in France
CONCLUSIONS: Lower rates of gynaecological screening among women without an RP compared to those with an RP may partly reflect a specific behaviour pattern in women less adherent to the health care system. However, this result also shows the importance of the RP, who assumes the key role of relaying public health information in a more personalised and adapted way.PMID:37644404 | PMC:PMC10464303 | DOI:10.1186/s12875-023-02122-5
Source: Primary Care - August 29, 2023 Category: Primary Care Authors: Lisa Ouanhnon Marie-Eve Rouge Bugat Vladimir Druel Pascale Grosclaude Cyrille Delpierre Source Type: research
Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis
Lancet Glob Health. 2023 Sep;11(9):e1345-e1362. doi: 10.1016/S2214-109X(23)00305-4.ABSTRACTBACKGROUND: The epidemiology of human papillomavirus (HPV) in women has been well documented. Less is known about the epidemiology of HPV in men. We aim to provide updated global and regional pooled overall, type-specific, and age-specific prevalence estimates of genital HPV infection in men.METHODS: We conducted a systematic review and meta-analysis to assess the prevalence of genital HPV infection in the general male population. We searched Embase, Ovid MEDLINE, and the Global Index Medicus for studies published between Jan 1, 1995...
Source: Cancer Control - August 17, 2023 Category: Cancer & Oncology Authors: Laia Bruni Ginesa Albero Jane Rowley Laia Alemany Marc Arbyn Anna R Giuliano Lauri E Markowitz Nathalie Broutet Melanie Taylor Source Type: research
Recommandations pour la pratique clinique Nice/Saint-Paul-de-Vence 2022 –2023 : Prise en charge du cancer du col de l'utérus avancé
Bull Cancer. 2023 Jun;110(6S):6S44-6S50. doi: 10.1016/S0007-4551(23)00333-8.ABSTRACTFrench recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2022-2023: Management of advanced cervical cancer The prognosis of cervical cancer remained pejorative until recently, first-line treatment consisting of platinum-based chemotherapy, associated with bevacizumab whenever possible, without any other therapeutic innovation for several years. However in 2022, immunotherapy appeared in the therapeutic landscape. Pembrolizumab can now be prescribed, thanks to the early access status granted by the HAS in September 2022, in pat...
Source: Bulletin du Cancer - August 12, 2023 Category: Cancer & Oncology Authors: Patricia Pautier Catherine Genestie Laurence Gladieff Jean-Emmanuel Kurtz Alain Lortholary Thibault de La Motte Rouge Anne-Lise Gaillard Anne Ducassou Coraline Dubot Etienne Rouleau Fabrice Narducci Sylvain Demontoy Christophe Hennequin Source Type: research
